Cargando…

An in Vitro Assay of hERG K(+) Channel Potency for a New EGFR Inhibitor FHND004

FHND004 is a newly synthesized epidermal growth factor receptor (EGFR) inhibitor for the treatment of non-small cell lung cancer (NSCLC). The aim of the present study was to investigate the impacts of FHND004 on human ether-à-go-go-related gene (hERG) K(+) channels and the molecular mechanisms under...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Tao, Hu, Bingxue, Chen, Shanshan, Wang, Qiang, Dong, Xue, Zhang, Yin, Zhu, Yongqiang, Zhang, Zhao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5990611/ https://www.ncbi.nlm.nih.gov/pubmed/29904349 http://dx.doi.org/10.3389/fphar.2018.00577

Ejemplares similares

hERG K(+) Channels Promote Survival of Irradiated Leukemia Cells
por: Palme, Daniela, et al.
Publicado: (2020)

Modulation of hERG K(+) Channel Deactivation by Voltage Sensor Relaxation
por: Shi, Yu Patrick, et al.
Publicado: (2020)

Stereoselective Inhibition of the hERG1 Potassium Channel
por: Grilo, Liliana Sintra, et al.
Publicado: (2010)

Voltage-Dependent Gating of hERG Potassium Channels
por: Cheng, Yen May, et al.
Publicado: (2012)

An Update on the Structure of hERG
por: Butler, Andrew, et al.
Publicado: (2020)

Stereoselective Blockage of Quinidine and Quinine in the hERG Channel and the Effect of Their Rescue Potency on Drug-Induced hERG Trafficking Defect
por: Yan, Meng, et al.
Publicado: (2016)

Structural modeling of the hERG potassium channel and associated drug interactions
por: Maly, Jan, et al.
Publicado: (2022)

Structural modeling of hERG channel–drug interactions using Rosetta
por: Emigh Cortez, Aiyana M., et al.
Publicado: (2023)

Evolutionary coupling analysis guides identification of mistrafficking-sensitive variants in cardiac K(+) channels: Validation with hERG
por: Zhang, Yihong, et al.
Publicado: (2022)

Molecular Insights Into the Gating Kinetics of the Cardiac hERG Channel, Illuminated by Structure and Molecular Dynamics
por: Zequn, Zheng, et al.
Publicado: (2021)

Saxitoxin Is a Gating Modifier of hERG K(+) Channels
por: Wang, Jixin, et al.
Publicado: (2003)

Up-Regulation of hERG K(+) Channels by B-RAF
por: Pakladok, Tatsiana, et al.
Publicado: (2014)

A k-nearest neighbor classification of hERG K(+) channel blockers
por: Chavan, Swapnil, et al.
Publicado: (2016)

Novel roles for hERG K(+) channels in cell proliferation and apoptosis
por: Jehle, J, et al.
Publicado: (2011)

Electrophysiological characterization of the modified hERG(T) potassium channel used to obtain the first cryo‐EM hERG structure
por: Zhang, Yihong, et al.
Publicado: (2020)

Ranolazine inhibition of hERG potassium channels: Drug–pore interactions and reduced potency against inactivation mutants
por: Du, Chunyun, et al.
Publicado: (2014)

Na(+) Permeation and Block of hERG Potassium Channels
por: Gang, Hongying, et al.
Publicado: (2006)

Data on the construction of a recombinant HEK293 cell line overexpressing hERG potassium channel and examining the presence of hERG mRNA and protein expression
por: Teah, Yi Fan, et al.
Publicado: (2017)

The N-linker region of hERG1a upregulates hERG1b potassium channels
por: Johnson, Ashley A., et al.
Publicado: (2022)

Vicious LQT induced by a combination of factors different from hERG inhibition
por: Xu, Xinping, et al.
Publicado: (2022)

Capsule Networks Showed Excellent Performance in the Classification of hERG Blockers/Nonblockers
por: Wang, Yiwei, et al.
Publicado: (2020)

Ensemble of structure and ligand-based classification models for hERG liability profiling
por: Vittorio, Serena, et al.
Publicado: (2023)

A Molecular Switch Driving Inactivation in the Cardiac K(+) Channel hERG
por: Köpfer, David A., et al.
Publicado: (2012)

Drug trapping in hERG K(+) channels: (not) a matter of drug size?
por: Linder, Tobias, et al.
Publicado: (2016)

Computational Tool for Fast in silico Evaluation of hERG K(+) Channel Affinity
por: Chemi, Giulia, et al.
Publicado: (2017)

Long-Chain Acylcarnitines Regulate the hERG Channel
por: Ferro, Fabio, et al.
Publicado: (2012)

hERG channel function: beyond long QT
por: Babcock, Joseph J, et al.
Publicado: (2013)

Towards a complete structure of the hERG channel
por: Schmidtke, Peter, et al.
Publicado: (2013)

Ion Conduction through the hERG Potassium Channel
por: Ceccarini, Luisa, et al.
Publicado: (2012)

Lipid regulation of hERG1 channel function
por: Miranda, Williams E., et al.
Publicado: (2021)

Gating Charges in the Activation and Inactivation Processes of the hERG Channel
por: Zhang, Mei, et al.
Publicado: (2004)

Early identification of hERG liability in drug discovery programs by automated patch clamp
por: Danker, Timm, et al.
Publicado: (2014)

Mechanisms underlying probucol-induced hERG-channel deficiency
por: Shi, Yuan-Qi, et al.
Publicado: (2015)

hERG1a N-terminal eag domain–containing polypeptides regulate homomeric hERG1b and heteromeric hERG1a/hERG1b channels: A possible mechanism for long QT syndrome
por: Trudeau, Matthew C., et al.
Publicado: (2011)

Experimentally Validated Pharmacoinformatics Approach to Predict hERG Inhibition Potential of New Chemical Entities
por: Munawar, Saba, et al.
Publicado: (2018)

The electric heart of hERG
por: Islas, León D.
Publicado: (2013)

Allosteric Coupling Between Drug Binding and the Aromatic Cassette in the Pore Domain of the hERG1 Channel: Implications for a State-Dependent Blockade
por: Kudaibergenova, Meruyert, et al.
Publicado: (2020)

The Basis for Low-affinity hERG Potassium Channel Block by Sotalol
por: Zhang, Yi Hong, et al.
Publicado: (2017)

Inhibition of hERG Potassium Channels by Celecoxib and Its Mechanism
por: Frolov, Roman V., et al.
Publicado: (2011)

Modification of hERG1 channel gating by Cd(2+)
por: Abbruzzese, Jennifer, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_uumbpe1r9kffksq0oigh366k5o